NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,153,000 | -68.1% | 71,950 | -32.0% | 0.18% | -51.8% |
Q4 2021 | $9,875,000 | -23.9% | 105,739 | -9.2% | 0.36% | -26.8% |
Q3 2021 | $12,980,000 | +2.5% | 116,479 | +4.4% | 0.50% | +16.7% |
Q2 2021 | $12,662,000 | +6.0% | 111,529 | -5.2% | 0.42% | -1.2% |
Q1 2021 | $11,940,000 | -27.2% | 117,589 | -28.7% | 0.43% | -30.0% |
Q4 2020 | $16,409,000 | -1.3% | 164,879 | -28.3% | 0.61% | -5.7% |
Q3 2020 | $16,621,000 | +44.4% | 230,079 | -0.3% | 0.65% | +29.9% |
Q2 2020 | $11,512,000 | +83.8% | 230,885 | +10.0% | 0.50% | +35.0% |
Q1 2020 | $6,265,000 | – | 209,810 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |